Bio-Rad at $345 Fair Value: Stability Suggests Hold, Not Buy
By stockpickr AI | March 1, 2026 | 10 min read
Investment Summary
Bio-Rad, a leader in life science and clinical diagnostics, shows stable performance but faces near-term revenue headwinds, suggesting a neutral to slightly positive long-term outlook based on intrinsic value.
Investment Recommendation
Hold
Fair Value: $345.50
Current Price: $328.11
Upside/Downside: +5.30%
The DCF valuation indicates the stock is currently trading close to its intrinsic value, supported by stable historical performance but muted growth projections.
Key Metrics
- No metrics available